SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CC532B77EDB6DABDB2B73D23661ECA0870793C70C73AFA2F9F4467CD52010F53E9DEB594BAF328E224106670F30DEEE7>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CC532B77EDB6DABDB2B73D23661ECA0870793C70C73AFA2F9F4467CD52010F53E9DEB594BAF328E224106670F30DEEE7
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CC532B77EDB6DABDB2B73D23661ECA0870793C70C73AFA2F9F4467CD52010F53E9DEB594BAF328E224106670F30DEEE7
http://www.w3.org/2000/01/rdf-schema#comment
"The identification of the MCAK/HLA-A*0201 and *2402 peptides suggests the possibility of designing peptide-based immunotherapeutic approaches that might prove effective in treating patients with MCAK-positive cancer."
xsd:string
http://purl.uniprot.org/uniprot/#_E9A5F02E76BB6B3504C74A3539A3A66763283D9365603E52DBFBD63F4C539A4EC3CF97ECBAD9849AA3D3309952E0873D
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CC532B77EDB6DABDB2B73D23661ECA0870793C70C73AFA2F9F4467CD52010F53E9DEB594BAF328E224106670F30DEEE7
http://purl.uniprot.org/uniprot/B7VCC4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CC532B77EDB6DABDB2B73D23661ECA0870793C70C73AFA2F9F4467CD52010F53E9DEB594BAF328E224106670F30DEEE7
http://purl.uniprot.org/uniprot/#_B7VCC4-mappedCitation-21165574
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CC532B77EDB6DABDB2B73D23661ECA0870793C70C73AFA2F9F4467CD52010F53E9DEB594BAF328E224106670F30DEEE7